AM
GILD icon

AGF Management’s Gilead Sciences GILD Stock Holding History

AGF Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.5M Sell
43,538
-8,470
-16% -$1.12M 0.02% 264
2026
Q1 		$7.25M Buy
52,008
+25,946
+100% +$3.63M 0.03% 231
2025
Q4 		$3.2M Buy
26,062
+3,159
+14% +$384K 0.01% 333
2025
Q3 		$2.54M Buy
22,903
+10,303
+82% +$1.17M 0.01% 467
2025
Q2 		$1.4M Buy
+12,600
New +$1.34M 0.01% 502
2024
Q4 		– Sell
-40,856
Closed -$3.43M – 709
2024
Q3 		$3.43M Buy
40,856
+3,831
+10% +$292K 0.02% 330
2024
Q2 		$2.54M Sell
37,025
-9,462
-20% -$631K 0.01% 346
2024
Q1 		$3.41M Sell
46,487
-205
-0.4% -$15.8K 0.02% 305
2023
Q4 		$3.78M Sell
46,692
-2,327
-5% -$181K 0.02% 303
2023
Q3 		$3.67M Sell
49,019
-4,323
-8% -$333K 0.03% 284
2023
Q2 		$4.11M Buy
53,342
+4,749
+10% +$379K 0.03% 274
2023
Q1 		$4.03M Sell
48,593
-61,578
-56% -$5.1M 0.03% 291
2022
Q4 		$9.46M Buy
+110,171
New +$8.72M 0.07% 201

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AGF Management's GILD Position: Q2 2026 in Review

AGF Management reduced its Gilead Sciences (GILD) stake by 16% in Q2 2026, selling an estimated $1.12M and leaving 43,538 shares worth $5.5M. The position accounts for 0.02% of the portfolio, ranked #264.

AGF Management first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $9.46M in Q4 2022. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AGF Management held 43,538 shares of Gilead Sciences worth $5.5M as of Q2 2026.
  • AGF Management sold 8,470 Gilead Sciences shares in Q2 2026, an estimated $1.12M.
  • Gilead Sciences made up 0.02% of AGF Management's portfolio in Q2 2026, its #264 holding.
  • AGF Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • AGF Management's Gilead Sciences position peaked at $9.46M in Q4 2022.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.